Literature DB >> 28444443

[New approaches for the prevention of actinic keratosis].

H Stege1, J Krutmann2.   

Abstract

Actinic keratosis is one of the most common skin diseases. Because of the ongoing demographic changes, it is anticipated that the incidence will further increase. Prevention of actinic keratoses is thus of great importance. By far the most important cause of actinic keratoses is the chronic cumulative irradiation of human skin with ultraviolet B and A radiation from natural sunlight. There is no doubt that use of sunscreens is effective in preventing actinic keratoses. Recent studies indicate that in high-risk groups the regular use of medical devices which are characterized by a very high SPF and which contain liposomally encapsulated DNA repair enzymes are effective in preventing the development of new actinic keratoses even when field cancerization is already present in human skin. There is also evidence that oral photoprotective strategies based on the regular intake of vitamin B3 may be used to prevent actinic keratoses.

Entities:  

Keywords:  DNA repair enzymes; Medical devices; Sunscreen products; Ultraviolet radiation; Vitamin B3

Mesh:

Substances:

Year:  2017        PMID: 28444443     DOI: 10.1007/s00105-017-3980-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  14 in total

1.  High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts.

Authors:  Hao Ou-Yang; Joseph Stanfield; Curtis Cole; Yohini Appa; Darrell Rigel
Journal:  J Am Acad Dermatol       Date:  2012-03-30       Impact factor: 11.527

Review 2.  Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  J Schmitt; A Seidler; T L Diepgen; A Bauer
Journal:  Br J Dermatol       Date:  2011-02       Impact factor: 9.302

3.  Developing clinical guidelines.

Authors:  P G Shekelle; S H Woolf; M Eccles; J Grimshaw
Journal:  West J Med       Date:  1999-06

Review 4.  Skin cancer induced by natural UV-radiation as an occupational disease—requirements for its notification and recognition.

Authors:  Thomas L Diepgen; Stephan Brandenburg; Werner Aberer; Andrea Bauer; Hans Drexler; Manigé Fartasch; Swen Malte John; Steffen Krohn; Stefanie Palfner; Wolfgang Römer; Uta Schuhmacher-Stock; Peter Elsner
Journal:  J Dtsch Dermatol Ges       Date:  2014-12       Impact factor: 5.584

5.  Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.

Authors:  Brian Berman; Clay J Cockerell
Journal:  J Am Acad Dermatol       Date:  2013-01       Impact factor: 11.527

6.  A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.

Authors:  Andrew C Chen; Andrew J Martin; Bonita Choy; Pablo Fernández-Peñas; Robyn A Dalziell; Catriona A McKenzie; Richard A Scolyer; Haryana M Dhillon; Janette L Vardy; Anne Kricker; Gayathri St George; Niranthari Chinniah; Gary M Halliday; Diona L Damian
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

7.  A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.

Authors:  L Eibenschutz; V Silipo; P De Simone; P L Buccini; A Ferrari; A Carbone; C Catricalà
Journal:  Br J Dermatol       Date:  2016-10-18       Impact factor: 9.302

8.  Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial.

Authors:  Rachel Neale; Gail Williams; Adèle Green
Journal:  Arch Dermatol       Date:  2002-10

9.  Prevention of polymorphic light eruption by oral administration of a nutritional supplement containing lycopene, β-carotene, and Lactobacillus johnsonii: results from a randomized, placebo-controlled, double-blinded study.

Authors:  Alessandra Marini; Thomas Jaenicke; Susanne Grether-Beck; Caroline Le Floc'h; Ahsène Cheniti; Nathalie Piccardi; Jean Krutmann
Journal:  Photodermatol Photoimmunol Photomed       Date:  2014-01-02       Impact factor: 3.135

10.  Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study.

Authors:  S Grether-Beck; A Marini; T Jaenicke; W Stahl; J Krutmann
Journal:  Br J Dermatol       Date:  2017-03-15       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.